GlassScriptPhysician profile
Meagan Platt
NPI 1871135962
$4,366.84
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2023: $831 · 2024: $3,411.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,963 · Education: $279.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,962.88 |
| Education | $278.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $794.97 | 2023-2024 | Airsupra, Breztri, Fasenra |
| Glaxosmithkline, LLC. | $770.19 | 2023-2024 | Nucala, Trelegy Ellipta, Arexvy |
| Harmony Biosciences LLC | $392.79 | 2021-2024 | Wakix |
| Takeda Pharmaceuticals U.S.A., INC. | $298.73 | 2024 | Glassia, Hyqvia, Cuvitru |
| Jazz Pharmaceuticals INC. | $274.51 | 2024 | |
| Genzyme Corporation | $247.46 | 2023-2024 | |
| Actelion Pharmaceuticals US, INC. | $240.33 | 2023-2024 | Uptravi, Opsumit |
| Avadel Cns Pharmaceuticals, LLC | $234.60 | 2023-2024 | Lumryz |
| Mallinckrodt Hospital Products INC. | $234.14 | 2023-2024 | Acthar |
| Regeneron Healthcare Solutions, INC. | $139.09 | 2024 | Dupixent |
| Merck Sharp & Dohme LLC | $132.85 | 2023-2024 | Winrevair |
| Boehringer Ingelheim Pharmaceuticals, INC. | $110.27 | 2023-2024 | Ofev |
| Amgen INC. | $99.31 | 2024 | Tezspire |
| Electromed, INC. | $79.66 | 2023-2024 | Smartvest |
| Baxter Healthcare | $76.57 | 2023-2024 | Hillrom - Volara System, Hillrom - Vest System Model 205 Acute Care |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Respicardia, INC. | $66.49 | 2024 | Remede System |
| Mylan Specialty L.P. | $54.93 | 2024 | Yupelri |
| Idorsia Pharmaceuticals US INC | $41.90 | 2023 | Quviviq |
| Philips North America LLC | $34.82 | 2024 | (O58) Sleep Respiratory Care Und |
| Pulmonx Corporation | $24.85 | 2024 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Bayer Healthcare Pharmaceuticals INC. | $18.38 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meagan Platt listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.